نتایج جستجو برای: brain metastases

تعداد نتایج: 520732  

Journal: :middle east journal of cancer 0
shamsiah abdul hamid biomedical imaging unit, faculty of medicine, university technology mara, sungai buloh, kuala lumpur, selangor, malaysia nur adura yaakup department of biomedical imaging, faculty of medicine, university of malaya, kuala lumpur, malaysia

the brain is a rare site for metastasis in most extracranial pediatric solid tumors, including wilm’s tumor. outcome for these patients are generally dismal. very few cases have been reported to have good survival even after therapy. this paper reports a case of stage iv wilm’s tumor with lung metastases in a patient who developed a solitary brain metastasis five months after completion of chem...

Journal: :The Cancer Journal 2017

Journal: :Wspolczesna Onkologia-Contemporary Oncology 2023

AMA Linh D, Thinh T, Hieu N, Duc N. Treatment outcomes of EGFR-TKI with or without locoregional brain therapy in advanced EGFR-mutant non-small cell lung cancer patients metastases. Contemporary Oncology/Współczesna Onkologia. 2023. doi:10.5114/wo.2023.129366. APA Linh, D., Thinh, T., Hieu, N., & Duc, (2023). https://doi.org/10.5114/wo.2023.129366 Chicago Do Mai, Tran Huy Nguyen-Van and Nguyen ...

Journal: :Neurosurgical Focus 2000

Journal: :Clinical & Experimental Metastasis 2017

2018
Ilana Slutzky-Shraga Alex Gorshtein Aharon Popovitzer Eyal Robenshtok Gloria Tsvetov Amit Akirov Dania Hirsch Carlos Benbassat

Brain metastases from non-medullary thyroid carcinoma (NMTC) are rare, with a reported frequency of ~1%, and patient survival time is <1 year after diagnosis. The optimal management of brain metastases in this setting continues to be debated. The aim of the present study was to evaluate a series of patients with brain metastases from NMTC attending a single tertiary medical center. The electron...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
N G Iskander A M Tsimberidou K Letourneau S Wen J J Wheler D S Hong A Naing R Kurzrock

e16546 Background: Patients with brain metastases are often excluded from clinical trials, but it is unclear if they pose an enhanced risk. METHODS We reviewed the records of 1,181 consecutive patients with and without brain metastases treated in the Phase I Clinical Trials Program. We compared clinical outcomes in patients who presented with and without brain metastases during the same time ...

Journal: :Annals of palliative medicine 2021

Background: Brain necrosis (RN) is a common radiotherapy sequela for brain metastases. Bevacizumab identified as therapeutic strategy RN. This study aimed to the clinical and radiobiological impacts on efficacy of in treating RN following stereotactic radiosurgery (SRS)

2009
M. D. Budde M. Resnick E. Gold E. K. Jordan

brain metastases (top) had poorly demarcated borders and were highly infiltrative with significant vasogenic edema. In contrast, bone metastases (bottom) had well-demarcated borders and developed as solid masses with minimal infiltration. Brain metastases (n=10) had significantly higher ADC and lower FA values than the normal brain tissue whereas bone metastases (n=5) had a significantly lower ...

Journal: :acta medica iranica 0
zinat miabi department of radiology, school of medicine, tabriz university of medical sciences, tabriz, iran.

a set of one hundred and twenty nine patients with known primary malignancy and suspected brain metastasis was reviewed in present study. the patients were selected among patients presented to the mri section of imam khomeini hospital or a private mri center in tabriz (iran). primary tumor site, clinical manifestations, number and site of lesions were identified in this patient population. the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید